Phathom Pharmaceuticals's total assets for Q1 2025 were $294.21M, a decrease of -22.23% from the previous quarter. PHAT total liabilities were $632.58M for the fiscal quarter, a 0.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.